290 related articles for article (PubMed ID: 27807241)
41. DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice.
Shen X; Wang S; Hao Y; Fu Y; Ren L; Li D; Tang W; Li J; Chen R; Zhu M; Wang S; Liu Y; Shao Y
Virol Sin; 2024 Jun; 39(3):490-500. PubMed ID: 38768713
[TBL] [Abstract][Full Text] [Related]
42. A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes.
Stefano ML; Kream RM; Stefano GB
Med Sci Monit; 2020 May; 26():e926016. PubMed ID: 32463026
[TBL] [Abstract][Full Text] [Related]
43. A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization.
Liu R; Wang J; Shao Y; Wang X; Zhang H; Shuai L; Ge J; Wen Z; Bu Z
Antiviral Res; 2018 Feb; 150():30-38. PubMed ID: 29246504
[TBL] [Abstract][Full Text] [Related]
44. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
[TBL] [Abstract][Full Text] [Related]
45. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.
Guo X; Deng Y; Chen H; Lan J; Wang W; Zou X; Hung T; Lu Z; Tan W
Immunology; 2015 Aug; 145(4):476-84. PubMed ID: 25762305
[TBL] [Abstract][Full Text] [Related]
46. Antibodies and vaccines against Middle East respiratory syndrome coronavirus.
Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L
Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078
[TBL] [Abstract][Full Text] [Related]
47. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
48. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
Tang J; Zhang N; Tao X; Zhao G; Guo Y; Tseng CT; Jiang S; Du L; Zhou Y
Hum Vaccin Immunother; 2015; 11(5):1244-50. PubMed ID: 25874632
[TBL] [Abstract][Full Text] [Related]
49. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.
Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X
PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294
[TBL] [Abstract][Full Text] [Related]
50. An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV.
Zhang H; Jin H; Yan F; Song Y; Dai J; Jiao C; Bai Y; Sun J; Liu D; Wang S; Zhang M; Lu J; Huang J; Huang P; Li Y; Xia X; Wang H
Virol Sin; 2023 Apr; 38(2):244-256. PubMed ID: 36587795
[TBL] [Abstract][Full Text] [Related]
51. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
Koch T; Dahlke C; Fathi A; Kupke A; Krähling V; Okba NMA; Halwe S; Rohde C; Eickmann M; Volz A; Hesterkamp T; Jambrecina A; Borregaard S; Ly ML; Zinser ME; Bartels E; Poetsch JSH; Neumann R; Fux R; Schmiedel S; Lohse AW; Haagmans BL; Sutter G; Becker S; Addo MM
Lancet Infect Dis; 2020 Jul; 20(7):827-838. PubMed ID: 32325037
[TBL] [Abstract][Full Text] [Related]
52. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
Plummer JR; McGettigan JP
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
[TBL] [Abstract][Full Text] [Related]
53. Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease.
Tao X; Garron T; Agrawal AS; Algaissi A; Peng BH; Wakamiya M; Chan TS; Lu L; Du L; Jiang S; Couch RB; Tseng CT
J Virol; 2016 Jan; 90(1):57-67. PubMed ID: 26446606
[TBL] [Abstract][Full Text] [Related]
54. Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells.
Kato T; Takami Y; Kumar Deo V; Park EY
J Biotechnol; 2019 Dec; 306():177-184. PubMed ID: 31614169
[TBL] [Abstract][Full Text] [Related]
55. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
Cavanagh D
Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
[TBL] [Abstract][Full Text] [Related]
56. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.
Schindewolf C; Menachery VD
Viruses; 2019 Jan; 11(1):. PubMed ID: 30658390
[TBL] [Abstract][Full Text] [Related]
57. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.
Agrawal AS; Tao X; Algaissi A; Garron T; Narayanan K; Peng BH; Couch RB; Tseng CT
Hum Vaccin Immunother; 2016 Sep; 12(9):2351-6. PubMed ID: 27269431
[TBL] [Abstract][Full Text] [Related]
58. Development of a diagnostic system for detection of specific antibodies and antigens against Middle East respiratory syndrome coronavirus.
Lee K; Ko HL; Lee EY; Park HJ; Kim YS; Kim YS; Cho NH; Park MS; Lee SM; Kim J; Kim H; Seong BL; Nam JH
Microbiol Immunol; 2018 Sep; 62(9):574-584. PubMed ID: 30117617
[TBL] [Abstract][Full Text] [Related]
59. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
Park JE; Shin HJ
Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
[TBL] [Abstract][Full Text] [Related]
60. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.
Blaney JE; Wirblich C; Papaneri AB; Johnson RF; Myers CJ; Juelich TL; Holbrook MR; Freiberg AN; Bernbaum JG; Jahrling PB; Paragas J; Schnell MJ
J Virol; 2011 Oct; 85(20):10605-16. PubMed ID: 21849459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
